Search research articles
Contact Us
Filters
Showing results (221-230 of 244) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain
D S Ernst, I F Tannock, E W Winquist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma
R J Motzer, A Rakhit, J Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1984
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies
A H Ross, P Grob, M Bothwell, et al.
Journal of Cardiovascular Electrophysiology
|
September 4, 1998
Nonfluoroscopic endocardial catheter mapping of atrial fibrillation
K H Kuck, S Ernst, R Cappato, et al.
Pediatric Research
|
August 1, 1996
Relationship of ventricular tachycardia to sleep/wakefulness in a model of sudden cardiac death
N S Moïse, D D Brittain, W J Flahive, et al.
Water Research
|
April 1, 2014
Assessment of relative potential for Legionella species or surrogates inhalation exposure from common water uses
Stephanie A Hines, Daniel J Chappie, Robert A Lordo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points
D J Bloomfield, M D Krahn, T Neogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2005
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group
C M Canil, M J Moore, E Winquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points
I F Tannock, D Osoba, M R Stockler, et al.
BMC Health Services Research
|
August 19, 2020
Acute neurological care in north-east Germany with telemedicine support (ANNOTeM): protocol of a multi-center, controlled, open-label, two-arm intervention study
J E Weber, A Angermaier, K Bollweg, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 244) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2003
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain
D S Ernst, I F Tannock, E W Winquist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma
R J Motzer, A Rakhit, J Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1984
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies
A H Ross, P Grob, M Bothwell, et al.
Journal of Cardiovascular Electrophysiology
|
September 4, 1998
Nonfluoroscopic endocardial catheter mapping of atrial fibrillation
K H Kuck, S Ernst, R Cappato, et al.
Pediatric Research
|
August 1, 1996
Relationship of ventricular tachycardia to sleep/wakefulness in a model of sudden cardiac death
N S Moïse, D D Brittain, W J Flahive, et al.
Water Research
|
April 1, 2014
Assessment of relative potential for Legionella species or surrogates inhalation exposure from common water uses
Stephanie A Hines, Daniel J Chappie, Robert A Lordo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points
D J Bloomfield, M D Krahn, T Neogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2005
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group
C M Canil, M J Moore, E Winquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1996
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points
I F Tannock, D Osoba, M R Stockler, et al.
BMC Health Services Research
|
August 19, 2020
Acute neurological care in north-east Germany with telemedicine support (ANNOTeM): protocol of a multi-center, controlled, open-label, two-arm intervention study
J E Weber, A Angermaier, K Bollweg, et al.
Page
of 25